Year |
Citation |
Score |
2019 |
Fazlollahi L, Hsiao SJ, Kochhar M, Mansukhani MM, Yamashiro DJ, Remotti HE. Malignant Rhabdoid Tumor, an Aggressive Tumor Often Misclassified as Small Cell Variant of Hepatoblastoma. Cancers. 11. PMID 31835848 DOI: 10.3390/Cancers11121992 |
0.458 |
|
2019 |
Banerjee D, Barton SM, Grabham PW, Rumeld AL, Okochi S, Street C, Kadenhe-Chiweshe A, Boboila S, Yamashiro DJ, Connolly EP. High-Dose Radiation increases Notch1 in tumor vasculature. International Journal of Radiation Oncology, Biology, Physics. PMID 31759078 DOI: 10.1016/J.Ijrobp.2019.11.010 |
0.451 |
|
2019 |
Banerjee D, Grabham PW, Boboila S, Barton SM, Yamashiro DJ, Connolly EP. High Dose Radiation Therapy (HDRT) Induces Notch1 Signaling in Endothelial Cells of Tumor Vasculature International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1034 |
0.49 |
|
2018 |
Boboila S, Lopez G, Yu J, Banerjee D, Kadenhe-Chiweshe A, Connolly EP, Kandel JJ, Rajbhandari P, Silva JM, Califano A, Yamashiro DJ. Transcription factor activating protein 4 is synthetically lethal and a master regulator of MYCN-amplified neuroblastoma. Oncogene. PMID 29880876 DOI: 10.1038/S41388-018-0326-9 |
0.317 |
|
2018 |
Gartrell RD, Sims JS, Barton SM, Kadenhe-Chiweshe A, Cruz FD, Turk AT, Kung AL, Bruce JN, Saenger YM, Yamashiro DJ, Connolly EP. Abstract B31: Multiparameter profiling of abscopal effect (AbE) in a pediatric fibrosarcoma with EML4-NTRK3 fusion Cancer Research. 78. DOI: 10.1158/1538-7445.Pedca17-B31 |
0.407 |
|
2018 |
Zenilman AL, Kadenhe-Chiweshe AV, Yamashiro DJ, Banerjee D. Notch1 Signaling in Neuroblastoma Tumor Vasculature after High-Dose Radiation Therapy Journal of the American College of Surgeons. 227. DOI: 10.1016/J.Jamcollsurg.2018.07.435 |
0.443 |
|
2018 |
Fazlollahi L, Hsiao SJ, Mansukhani MM, Bender JLG, Kung AL, Yamashiro DJ, Remotti HE. INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor Human Pathology: Case Reports. 12: 42-47. DOI: 10.1016/J.Ehpc.2018.02.001 |
0.456 |
|
2017 |
Banerjee D, Boboila S, Street C, Okochi S, Cruz FSD, Connolly E, Kadenhe-Chiweshe A, Yamashiro D. Abstract 702: A novel cell-penetrating ATF5 antagonist peptide CP-d/n-ATF5 exertsin vitroandin vivoanti-tumor effects in a broad spectrum of pediatric cancers Cancer Research. 77: 702-702. DOI: 10.1158/1538-7445.Am2017-702 |
0.353 |
|
2017 |
Barton SM, Okochi S, Street C, Banerjee D, Kadenhe-Chiweshe A, Yamashiro DJ, Connolly EP. Poster ViewingCombined Stereotactic Body Radiation Therapy and Immune Checkpoint Inhibition Slows Tumor Growth in a Novel Syngeneic Model of Neuroblastoma International Journal of Radiation Oncology Biology Physics. 99. DOI: 10.1016/J.Ijrobp.2017.06.1989 |
0.432 |
|
2016 |
Dela Cruz FS, Diolaiti D, Turk AT, Rainey AR, Ambesi-Impiombato A, Andrews SJ, Mansukhani MM, Nagy PL, Alvarez MJ, Califano A, Forouhar F, Modzelewski B, Mitchell CM, Yamashiro DJ, Marks LJ, et al. A case study of an integrative genomic and experimental therapeutic approach for rare tumors: identification of vulnerabilities in a pediatric poorly differentiated carcinoma. Genome Medicine. 8: 116. PMID 27799065 DOI: 10.1186/S13073-016-0366-0 |
0.354 |
|
2016 |
Tavana O, Li D, Dai C, Lopez G, Banerjee D, Kon N, Chen C, Califano A, Yamashiro DJ, Sun H, Gu W. HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nature Medicine. PMID 27618649 DOI: 10.1038/Nm.4180 |
0.352 |
|
2016 |
Bender JLG, Oberg JA, Sulis ML, Cruz FD, Sireci AN, Hsiao SJ, Yamashiro DJ, Koval C, Chung WK, Emerson SG, Zylber R, Cano S, Denney DP, Andrews S, Nagy PL, et al. Abstract PR01: Precision in Pediatric Sequencing (PIPseq): Clinical implementation of genomic sequencing into pediatric hematology-oncology practice Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pmsclingen15-Pr01 |
0.324 |
|
2016 |
Fazlollahi L, Hsiao S, Mansukhani M, Bender JG, Kung A, Yamashiro D, Remotti H. Abstract A27: INI1 negative hepatoblastoma, a vanishing entity representing malignant rhabdoid tumor Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Devbiolca15-A27 |
0.433 |
|
2015 |
Jani A, Shaikh F, Barton S, Willis C, Banerjee D, Mitchell J, Hernandez SL, Hei T, Kadenhe-Chiweshe A, Yamashiro DJ, Connolly EP. High-Dose, Single-Fraction Irradiation Rapidly Reduces Tumor Vasculature and Perfusion in a Xenograft Model of Neuroblastoma. International Journal of Radiation Oncology, Biology, Physics. PMID 26907918 DOI: 10.1016/J.Ijrobp.2015.12.367 |
0.755 |
|
2015 |
Banerjee D, Hernandez SL, Garcia A, Kangsamaksin T, Sbiroli E, Andrews J, Forrester LA, Wei N, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch suppresses angiogenesis and progression of hepatic metastases. Cancer Research. 75: 1592-602. PMID 25744722 DOI: 10.1158/0008-5472.Can-14-1493 |
0.71 |
|
2015 |
Zhang S, Lopez G, Yu J, Silva J, Kadenhe-Chiweshe A, Califano A, Yamashiro D. Abstract 2083: TFAP4 inhibits differentiation of MYCN-amplified neuroblastoma Cancer Research. 75: 2083-2083. DOI: 10.1158/1538-7445.Am2015-2083 |
0.301 |
|
2015 |
Jani A, Shaikh F, Kadenhe-Chiweshe A, Hernandez S, Hei T, Yamashiro D, Connolly EP. High-Dose Radiation Leads to Rapid Changes in Tumor Perfusion and Vascular Remodeling International Journal of Radiation Oncology Biology Physics. 93. DOI: 10.1016/J.Ijrobp.2015.07.1938 |
0.74 |
|
2014 |
Shaikh F, Kadenhe-Chiweshe A, Hernandez S, Forrester LA, Sun Y, Hei TK, Yamashiro D, Connolly EP. Modeling Radiation-Induced Vascular Effects of High-Dose Versus Standard-Dose Radiation in an Orthotopic Mouse Model of High-Risk Neuroblastoma International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.2125 |
0.672 |
|
2013 |
Hernandez SL, Banerjee D, Garcia A, Kangsamaksin T, Cheng WY, Anastassiou D, Funahashi Y, Kadenhe-Chiweshe A, Shawber CJ, Kitajewski JK, Kandel JJ, Yamashiro DJ. Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis. Vascular Cell. 5: 17. PMID 24066611 DOI: 10.1186/2045-824X-5-17 |
0.771 |
|
2013 |
Liou P, Bader L, Wang A, Yamashiro D, Kandel JJ. Correlation of tumor-associated macrophages and clinicopathological factors in Wilms tumor. Vascular Cell. 5: 5. PMID 23514200 DOI: 10.1186/2045-824X-5-5 |
0.448 |
|
2013 |
Ma TC, Langley B, Ko B, Wei N, Gazaryan IG, Zareen N, Yamashiro DJ, Willis DE, Ratan RR. A screen for inducers of p21(waf1/cip1) identifies HIF prolyl hydroxylase inhibitors as neuroprotective agents with antitumor properties. Neurobiology of Disease. 49: 13-21. PMID 22944173 DOI: 10.1016/J.Nbd.2012.08.016 |
0.344 |
|
2013 |
Zhang S, Yu J, Wei N, Silva J, Kandel JJ, Yamashiro DJ. Abstract 1132: Identification of synthetic lethal genes to MYCN-amplified neuroblastoma. Cancer Research. 73: 1132-1132. DOI: 10.1158/1538-7445.Am2013-1132 |
0.303 |
|
2013 |
Borden M, Sirsi S, Hernandez S, Homma S, Kandel J, Yamashiro D. Polyplex-microbubbles for improved ultrasound-mediated gene therapy The Journal of the Acoustical Society of America. 133: 3409-3409. DOI: 10.1121/1.4805948 |
0.659 |
|
2013 |
Sirsi SR, Yamashiro D, Kandel J, Borden M. Polyplex-microbubbles for ultrasound-mediated gene therapy Proceedings of Meetings On Acoustics. 19. DOI: 10.1121/1.4801416 |
0.307 |
|
2012 |
Glade Bender J, Blaney SM, Borinstein S, Reid JM, Baruchel S, Ahern C, Ingle AM, Yamashiro DJ, Chen A, Weigel B, Adamson PC, Park JR. A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 5081-9. PMID 22791883 DOI: 10.1158/1078-0432.Ccr-12-0078 |
0.359 |
|
2012 |
Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D. A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. Plos One. 7: e34705. PMID 22493711 DOI: 10.1371/Journal.Pone.0034705 |
0.355 |
|
2012 |
Sirsi SR, Flexman ML, Vlachos F, Huang J, Hernandez SL, Kim HK, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Hielscher AH, Kandel JJ, Yamashiro DJ, Borden MA. Contrast ultrasound imaging for identification of early responder tumor models to anti-angiogenic therapy. Ultrasound in Medicine & Biology. 38: 1019-29. PMID 22425376 DOI: 10.1016/J.Ultrasmedbio.2012.01.014 |
0.764 |
|
2012 |
Flexman ML, Vlachos F, Kim HK, Sirsi SR, Huang J, Hernandez SL, Johung TB, Gander JW, Reichstein AR, Lampl BS, Wang A, Borden MA, Yamashiro DJ, Kandel JJ, Hielscher AH. Monitoring early tumor response to drug therapy with diffuse optical tomography. Journal of Biomedical Optics. 17: 016014. PMID 22352664 DOI: 10.1117/1.Jbo.17.1.016014 |
0.768 |
|
2012 |
Sirsi SR, Hernandez SL, Zielinski L, Blomback H, Koubaa A, Synder M, Homma S, Kandel JJ, Yamashiro DJ, Borden MA. Polyplex-microbubble hybrids for ultrasound-guided plasmid DNA delivery to solid tumors. Journal of Controlled Release : Official Journal of the Controlled Release Society. 157: 224-34. PMID 21945680 DOI: 10.1016/J.Jconrel.2011.09.071 |
0.721 |
|
2012 |
Garcia A, Banerjee D, Kitajewski JK, Kandel JJ, Yamashiro DJ. Abstract 2325: Increase in neuroblastoma metastasis after dual inhibition of VEGF and Notch Cancer Research. 72: 2325-2325. DOI: 10.1158/1538-7445.Am2012-2325 |
0.549 |
|
2012 |
Garcia A, Banerjee D, Hernandez S, Alfonso R, Thirumoorthi A, Andrews J, Sbiroli E, Kadenhe-Chiweshe A, Yamashiro DJ, Kandel JJ. Inhibition of host Notch function disrupts hepatic vasculature, and promotes tumor growth Journal of the American College of Surgeons. 215. DOI: 10.1016/J.Jamcollsurg.2012.06.195 |
0.727 |
|
2011 |
Glade Bender J, Yamashiro DJ, Fox E. Clinical development of VEGF signaling pathway inhibitors in childhood solid tumors. The Oncologist. 16: 1614-25. PMID 22042784 DOI: 10.1634/Theoncologist.2011-0148 |
0.424 |
|
2011 |
Fisher JC, Gander JW, Haley MJ, Hernandez SL, Huang J, Chang YJ, Johung TB, Guarnieri P, O'Toole K, Yamashiro DJ, Kandel JJ. Inhibition of cyclo-oxygenase 2 reduces tumor metastasis and inflammatory signaling during blockade of vascular endothelial growth factor. Vascular Cell. 3: 22. PMID 21978392 DOI: 10.1186/2045-824X-3-22 |
0.783 |
|
2011 |
Flexman ML, Kim HK, Hernandez SL, Huang J, Johung TJ, Lee J, Yamashiro DJ, Kandel JJ, Hielscher AH. Optical tomographic monitoring of vascular responses to anti-angiogenic drugs in preclinical tumor models Progress in Biomedical Optics and Imaging - Proceedings of Spie. 7896. DOI: 10.1117/12.875422 |
0.77 |
|
2010 |
Lee J, Pöschinger T, Hernandez SL, Huang J, Johung T, Kandel J, Yamashiro DJ, Hielscher AH. Dynamic fluorescence imaging for the detection of vascular changes in anti-angiogenic drug therapy Optics Infobase Conference Papers. DOI: 10.1364/Biomed.2010.Jma74 |
0.681 |
|
2010 |
Flexman ML, Hernandez SL, Huang J, Johung T, Kim HK, Lee J, Vlachos F, Yamashiro DJ, Kandel J, Hielscher AH. Early Detection of Tumor Vascular Response to Anti-Angiogenic Drugs with Optical Tomography Ieee Transactions On Biomedical Engineering. DOI: 10.1364/Biomed.2010.Btud10 |
0.728 |
|
2010 |
Lee A, Handler C, Harrison L, Shen WV, Gates L, Wells RJ, Wolff JE, Garvin JH, Yamashiro D, Cairo MS. Pilot study of the novel chemotherapy regimen of topotecan, ifosfamide, and carboplatin (TIC) in children with refractory/recurrent solid tumors. Journal of Clinical Oncology. 28: 9545-9545. DOI: 10.1200/Jco.2010.28.15_Suppl.9545 |
0.395 |
|
2010 |
Park JR, Hawkins DS, Ingle M, Borinstein SC, Bender JLG, Yamashiro D, Baruchel S, Chen AP, Adamson PC, Blaney S. A pediatric phase I trial and pharmacokinetic study of aflibercept (VEGF Trap): A Children's Oncology Group Phase I Consortium study. Journal of Clinical Oncology. 28: 9530-9530. DOI: 10.1200/Jco.2010.28.15_Suppl.9530 |
0.438 |
|
2010 |
Hernandez SL, Funahashi Y, Sharma A, Kitajewski JK, Kandel JJ, Yamashiro DJ. Abstract 1282: Notch and VEGF regulate tumor endothelial cell survival Cancer Research. 70: 1282-1282. DOI: 10.1158/1538-7445.Am10-1282 |
0.765 |
|
2009 |
Boo YJ, Fisher JC, Haley MJ, Cowles RA, Kandel JJ, Yamashiro DJ. Vascular characterization of clear cell sarcoma of the kidney in a child: a case report and review. Journal of Pediatric Surgery. 44: 2031-6. PMID 19853769 DOI: 10.1016/J.Jpedsurg.2009.06.023 |
0.477 |
|
2009 |
Zaghloul N, Hernandez SL, Bae JO, Huang J, Fisher JC, Lee A, Kadenhe-Chiweshe A, Kandel JJ, Yamashiro DJ. Vascular endothelial growth factor blockade rapidly elicits alternative proangiogenic pathways in neuroblastoma. International Journal of Oncology. 34: 401-7. PMID 19148474 DOI: 10.3892/Ijo_00000163 |
0.784 |
|
2009 |
Levy CF, Oo KZ, Fireman F, Pierre L, Bania MA, Sadanandan S, Yamashiro DJ, Glade Bender JL. Reversible posterior leukoencephalopathy syndrome in a child treated with bevacizumab. Pediatric Blood & Cancer. 52: 669-71. PMID 19101996 DOI: 10.1002/Pbc.21866 |
0.383 |
|
2009 |
Huang J, Bae JO, Tsai JP, Kadenhe-Chiweshe A, Papa J, Lee A, Zeng S, Kornfeld ZN, Ullner P, Zaghloul N, Ioffe E, Nandor S, Burova E, Holash J, Thurston G, ... ... Yamashiro DJ, et al. Angiopoietin-1/Tie-2 activation contributes to vascular survival and tumor growth during VEGF blockade. International Journal of Oncology. 34: 79-87. PMID 19082480 DOI: 10.3892/Ijo_00000131 |
0.563 |
|
2009 |
Rothenberg AB, Berdon WE, D'Angio GJ, Yamashiro DJ, Cowles RA. Neuroblastoma-remembering the three physicians who described it a century ago: James Homer Wright, William Pepper, and Robert Hutchison. Pediatric Radiology. 39: 155-60. PMID 19034443 DOI: 10.1007/S00247-008-1062-Z |
0.395 |
|
2008 |
Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva DM, Suzuki A, Wang X, Shawber CJ, Kandel JJ, Yamashiro DJ, et al. A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Research. 68: 4727-35. PMID 18559519 DOI: 10.1158/0008-5472.Can-07-6499 |
0.758 |
|
2008 |
Kadenhe-Chiweshe A, Papa J, McCrudden KW, Frischer J, Bae JO, Huang J, Fisher J, Lefkowitch JH, Feirt N, Rudge J, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. Sustained VEGF blockade results in microenvironmental sequestration of VEGF by tumors and persistent VEGF receptor-2 activation. Molecular Cancer Research : McR. 6: 1-9. PMID 18234958 DOI: 10.1158/1541-7786.Mcr-07-0101 |
0.513 |
|
2008 |
Glade Bender JL, Adamson PC, Reid JM, Xu L, Baruchel S, Shaked Y, Kerbel RS, Cooney-Qualter EM, Stempak D, Chen HX, Nelson MD, Krailo MD, Ingle AM, Blaney SM, Kandel JJ, ... Yamashiro DJ, et al. Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 399-405. PMID 18202416 DOI: 10.1200/Jco.2007.11.9230 |
0.411 |
|
2006 |
Lee A, Frischer J, Serur A, Huang J, Bae JO, Kornfield ZN, Eljuga L, Shawber CJ, Feirt N, Mansukhani M, Stempak D, Baruchel S, Glade Bender J, Kandel JJ, Yamashiro DJ. Inhibition of cyclooxygenase-2 disrupts tumor vascular mural cell recruitment and survival signaling. Cancer Research. 66: 4378-84. PMID 16618763 DOI: 10.1158/0008-5472.Can-05-3810 |
0.547 |
|
2006 |
Bender JLG, Adamson PC, Baruchel S, Shaked Y, Chen HX, Reid JM, Ingle AM, Blaney SM, Kandel JJ, Yamashiro DJ. A phase I study of bevacizumab in children with refractory solid tumors: A Children's Oncology Group study Journal of Clinical Oncology. 24: 9017-9017. DOI: 10.1200/Jco.2006.24.18_Suppl.9017 |
0.446 |
|
2006 |
Masciotti J, Provenzano F, Papa J, Klose A, Hur J, Gu X, Yamashiro D, Kandel J, Hielscher AH. Monitoring tumor growth and treatment in small animals with magnetic resonance and optical tomographic imaging Proceedings of Spie - the International Society For Optical Engineering. 6081. DOI: 10.1117/12.647138 |
0.367 |
|
2006 |
Papa JC, Kadenhe-Chiweshe A, McCrudden K, Huang J, Yamashiro D, Kandel J. AML-1/Angiopoietin signaling contributes to hepatoblastoma recurrence during VEGF blockade Journal of the American College of Surgeons. 203. DOI: 10.1016/J.Jamcollsurg.2006.05.131 |
0.371 |
|
2005 |
Yuan E, Li CM, Yamashiro DJ, Kandel J, Thaker H, Murty VV, Tycko B. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors. Molecular Cancer Research : McR. 3: 493-502. PMID 16179496 DOI: 10.1158/1541-7786.Mcr-05-0082 |
0.368 |
|
2005 |
Masciotti J, Abdoulaev G, Hur J, Papa J, Bae J, Huang J, Yamashiro D, Kandel J, Hielscher AH. Combined optical tomographic and magnetic resonance imaging of tumor bearing mice Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5693: 74-81. DOI: 10.1117/12.590844 |
0.346 |
|
2004 |
Glade Bender J, Cooney EM, Kandel JJ, Yamashiro DJ. Vascular remodeling and clinical resistance to antiangiogenic cancer therapy. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 7: 289-300. PMID 15533766 DOI: 10.1016/J.Drup.2004.09.001 |
0.406 |
|
2004 |
Frischer JS, Huang J, Serur A, Kadenhe-Chiweshe A, McCrudden KW, O'Toole K, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature International Journal of Oncology. 25: 549-553. PMID 15289855 DOI: 10.3892/Ijo.25.3.549 |
0.583 |
|
2004 |
Huang J, Frischer JS, New T, Kim ES, Serur A, Lee A, Kadenhe-Chiwishe A, Pollyea DA, Yokoi A, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. TNP-470 promotes initial vascular sprouting in xenograft tumors Molecular Cancer Therapeutics. 3: 335-343. PMID 15026554 |
0.503 |
|
2004 |
Frischer JS, Huang J, Serur A, Kadenhe A, Yamashiro DJ, Kandel JJ. Biomolecular markers and involution of hemangiomas. Journal of Pediatric Surgery. 39: 400-4. PMID 15017560 DOI: 10.1016/J.Jpedsurg.2003.11.043 |
0.322 |
|
2004 |
Huang J, Softer SZ, Kim ES, McCrudden KW, New T, Manley CA, Middlesworth W, O'Toole K, Yamashiro DJ, Kandel JJ. Vascular Remodeling Marks Tumors That Recur during Chronic Suppression of Angiogenesis Molecular Cancer Research. 2: 36-42. PMID 14757844 |
0.484 |
|
2003 |
Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, O'Toole K, Yamashiro DJ, Kandel JJ. Human Epidermal Growth Factor Receptor Signaling Contributes to Tumor Growth Via Angiogenesis in her2/neu-Expressing Experimental Wilms' Tumor Journal of Pediatric Surgery. 38: 1569-1573. PMID 14614702 DOI: 10.1016/S0022-3468(03)00562-1 |
0.455 |
|
2003 |
Kaicker S, McCrudden KW, Beck L, New T, Huang J, Frischer JS, Serur A, Kadenhe-Chiweshe A, Yokoi A, Kandel JJ, Yamashiro DJ. Thalidomide is anti-angiogenic in a xenograft model of neuroblastoma International Journal of Oncology. 23: 1651-1655. PMID 14612937 DOI: 10.3892/Ijo.23.6.1651 |
0.558 |
|
2003 |
Yokoi A, McCrudden KW, Huang J, Kim ES, Soffer SZ, Frischer JS, Serur A, New T, Yuan J, Mansukhani M, Otoole K, Yamashiro DJ, Kandel JJ. Blockade of her2/neu decreases VEGF expression but does not alter HIF-1 distribution in experimental Wilms tumor Oncology Reports. 10: 1271-1274. PMID 12883692 DOI: 10.3892/Or.10.5.1271 |
0.514 |
|
2003 |
Huang J, Frischer JS, Serur A, Kadenhe A, Yokoi A, McCrudden KW, New T, O'Toole K, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Yamashiro DJ, Kandel JJ. Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proceedings of the National Academy of Sciences of the United States of America. 100: 7785-90. PMID 12805568 DOI: 10.1073/Pnas.1432908100 |
0.524 |
|
2003 |
Glade-Bender J, Kandel JJ, Yamashiro DJ. VEGF blocking therapy in the treatment of cancer. Expert Opinion On Biological Therapy. 3: 263-76. PMID 12662141 DOI: 10.1517/14712598.3.2.263 |
0.432 |
|
2003 |
McCrudden KW, Hopkins B, Frischer J, Novikov A, Huang J, Kadenhe A, New T, Yokoi A, Yamashiro DJ, Kandel JJ, Middlesworth W, Grosfeld J, Gittes G, Chochat S. Anti-VEGF antibody in experimental hepatoblastoma: Suppression of tumor growth and altered angiogenesis Journal of Pediatric Surgery. 38: 308-314. PMID 12632340 DOI: 10.1053/Jpsu.2003.50099 |
0.399 |
|
2002 |
Kim ES, Serur A, Huang J, Manley CA, McCrudden KW, Frischer JS, Soffer SZ, Ring L, New T, Zabski S, Rudge JS, Holash J, Yancopoulos GD, Kandel JJ, Yamashiro DJ. Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma. Proceedings of the National Academy of Sciences of the United States of America. 99: 11399-404. PMID 12177446 DOI: 10.1073/Pnas.172398399 |
0.557 |
|
2002 |
McCrudden KW, Yokoi A, Thosani A, Soffer SZ, Kim ES, Huang J, Manley C, O'Toole K, Yamashiro DJ, Kandel JJ, Middlesworth W. Topotecan is anti-angiogenic in experimental hepatoblastoma Journal of Pediatric Surgery. 37: 857-861. PMID 12037749 DOI: 10.1053/Jpsu.2002.32887 |
0.389 |
|
2002 |
Soffer SZ, Kim E, Huang J, McCrudden K, Yokoi A, Moore JT, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro DJ, Kandel JJ. Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts. Journal of Pediatric Surgery. 37: 528-32. PMID 11877682 DOI: 10.1053/Jpsu.2002.30859 |
0.55 |
|
2002 |
Huang J, Soffer SZ, Kim ES, Yokoi A, Moore JT, McCrudden KW, Manley C, Middlesworth W, O'Toole K, Stolar C, Yamashiro DJ, Kandel JJ. p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease. Journal of Pediatric Surgery. 37: 523-7. PMID 11877681 DOI: 10.1053/Jpsu.2002.30858 |
0.527 |
|
2002 |
Kim ES, Soffer SZ, Huang J, McCrudden KW, Yokoi A, Manley CA, Middlesworth W, Kandel JJ, Yamashiro DJ. Distinct response of experimental neuroblastoma to combination antiangiogenic strategies Journal of Pediatric Surgery. 37: 518-522. PMID 11877680 DOI: 10.1053/Jpsu.2002.30855 |
0.417 |
|
2001 |
Soffer SZ, Kim E, Moore JT, Huang J, Yokoi A, Manley C, O'Toole K, Middlesworth W, Stolar C, Yamashiro D, Kandel J. Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor. Journal of Pediatric Surgery. 36: 1781-4. PMID 11733906 DOI: 10.1053/Jpsu.2001.28823 |
0.535 |
|
2001 |
Moore J, Lee M, Garzon M, Soffer S, Kim E, Saouaf R, del Toro G, Yamashiro D, Kandel J. Effective therapy of a vascular tumor of infancy with vincristine. Journal of Pediatric Surgery. 36: 1273-6. PMID 11479875 DOI: 10.1053/Jpsu.2001.25793 |
0.429 |
|
2001 |
Soffer SZ, Moore JT, Kim E, Huang J, Yokoi A, Manley C, O'Toole K, Stolar C, Middlesworth W, Yamashiro DJ, Kandel JJ. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. Journal of Pediatric Surgery. 36: 1177-81. PMID 11479851 DOI: 10.1053/Jpsu.2001.25747 |
0.556 |
|
2001 |
Kim E, Moore J, Huang J, Soffer S, Manley CA, O'Toole K, Middlesworth W, Stolar CJ, Kandel JJ, Yamashiro DJ. All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor. Journal of Pediatric Surgery. 36: 287-90. PMID 11172417 DOI: 10.1053/Jpsu.2001.20691 |
0.558 |
|
1997 |
Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. Journal of Pediatric Hematology Oncology. 19: 93-101. PMID 9149737 DOI: 10.1097/00043426-199703000-00001 |
0.387 |
|
Show low-probability matches. |